Martha Shackleton
Impact in
- Ophthalmology top 2%
- Glaucoma and retinal disorders
- Retinal Diseases and Treatments
- Ocular Infections and Treatments
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
Papers in
-
- Glaucoma and retinal disorders 6
- Retinal Diseases and Treatments 4
- Drug-Induced Ocular Toxicity 3
-
- Receptor Mechanisms and Signaling 1
- Co-authors
- Andrew Acheampong (5 shared papers)Diane Tang‐Liu (6 shared papers)D. Tang–Liu (1 shared paper)J. Burke (1 shared paper)B. A. John (1 shared paper)Larry A. Wheeler (1 shared paper)Robert S. Decker (1 shared paper)Janet A. Anderson (1 shared paper)
- Journals
- Journal of Ocular Pharmacology and Therapeutics (4 papers)Drug Metabolism and Disposition (2 papers)Advances in experimental medicine and biology (1 paper)Journal of Pharmaceutical Sciences (1 paper)Current Eye Research (1 paper)
- Partner nations
- IrelandUnited States
In The Last Decade
Martha Shackleton
10 papers receiving 344 citations
Peers
Comparison fields: 5 of 54
- Ophthalmology 168
- Pharmaceutical Science 75
- Public Health, Environmental and Occupational Health 114
- Radiology, Nuclear Medicine and Imaging 62
- Pharmacology 42
Countries citing papers authored by Martha Shackleton
This map shows the geographic impact of Martha Shackleton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martha Shackleton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martha Shackleton more than expected).
Fields of papers citing papers by Martha Shackleton
This network shows the impact of papers produced by Martha Shackleton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martha Shackleton. The network helps show where Martha Shackleton may publish in the future.
Co-authors
The 14 scholars most cited alongside Martha Shackleton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 106 | |
| 2 | 1995 | 75 | |
| 3 | 1999 | 68 | |
| 4 | 1982 | 32 | |
| 5 | 1995 | 27 | |
| 6 | 1996 | 18 | |
| 7 | 1988 | 12 | |
| 8 | 1998 | 12 | |
| 9 | 1987 | 11 | |
| 10 | 1988 | 10 |
About Martha Shackleton
Martha Shackleton is a scholar working on Ophthalmology, Molecular Biology, Pharmacology, Pharmacology and Biochemistry, having authored 10 papers that have together received 371 indexed citations. Recurring topics across this work include Glaucoma and retinal disorders (6 papers), Retinal Diseases and Treatments (4 papers), Drug-Induced Ocular Toxicity (3 papers), Eicosanoids and Hypertension Pharmacology (2 papers), Inflammatory mediators and NSAID effects (2 papers), Plant-based Medicinal Research (2 papers), Receptor Mechanisms and Signaling (1 paper) and Essential Oils and Antimicrobial Activity (1 paper). The work is most often cited by research in Ophthalmology (168 citations), Pharmaceutical Science (75 citations), Public Health, Environmental and Occupational Health (114 citations), Radiology, Nuclear Medicine and Imaging (62 citations) and Pharmacology (42 citations). Martha Shackleton has collaborated with scholars based in Ireland and United States. Frequent co-authors include Andrew Acheampong, Diane Tang‐Liu, D. Tang–Liu, J. Burke, B. A. John, Larry A. Wheeler, Robert S. Decker, Janet A. Anderson, Wendy Luo and C Madhu. Their work appears in journals such as Journal of Ocular Pharmacology and Therapeutics, Drug Metabolism and Disposition, Advances in experimental medicine and biology, Journal of Pharmaceutical Sciences and Current Eye Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.